Katsuki Masahito, Matsumori Yasuhiko, Kawahara Junko, Yamagishi Chinami, Koh Akihito, Kawamura Shin, Kashiwagi Kenta, Kito Tomohiro, Oguri Masato, Mizuno Shoji, Nakamura Kentaro, Hayakawa Katsushi, Ohta Osamu, Kubota Noa, Nakamura Hina, Aoyama Jun, Yamazaki Isamu, Mizusawa Satoshi, Ueki Yasuhide, Nanri Maiko, Miyakoshi Yuki, Gobo Shuto, Entani Akio, Yamamoto Toshiko, Otake Miyako, Ikeda Takashi, Matsuo Mitsuhiro, Yamagishi Fuminori
Department of Neurosurgery, Itoigawa General Hospital, Itoigawa, Japan.
Department of Neurology, Sendai Headache and Neurology Clinic, Sendai, Japan.
Headache. 2023 Mar;63(3):429-440. doi: 10.1111/head.14472. Epub 2023 Jan 27.
OBJECTIVE: We prospectively performed the Itoigawa Headache Awareness Campaign from August 2021 to June 2022, with two main interventions, and evaluated its effectiveness. BACKGROUND: Headache is a common public health problem, but its burden could be reduced by raising awareness about headache and the appropriate use of acute and prophylactic medication. However, few studies on raising headache awareness in the general public have been reported. METHODS: The target group was the general public aged 15-64. We performed two main interventions synergistically supported by other small interventions. Intervention 1 included leaflet distribution and a paper-based questionnaire about headache during COVID-19 vaccination, and intervention 2 included on-demand e-learning and online survey through schools. In these interventions, we emphasize the six important topics for the general public that were described in the Clinical Practice Guideline for Headache Disorders 2021. Each response among the two interventions' cohorts was collected on pre and post occasions. The awareness of the six topics before and after the campaign was evaluated. RESULTS: We obtained 4016 valid responses from 6382 individuals who underwent vaccination in intervention 1 and 2577 from 594 students and 1983 parents in intervention 2; thus, 6593 of 20,458 (32.2%) of the overall working-age population in Itoigawa city experienced these interventions. The percentage of individuals' aware of the six topics significantly increased after the two main interventions ranging from 6.6% (39/594)-40.0% (1606/4016) to 64.1% (381/594)-92.6% (1836/1983) (p < 0.001, all). CONCLUSIONS: We conducted this campaign through two main interventions with an improved percentage of individuals who know about headache. The two methods of community-based interventions could raise headache awareness effectively. Furthermore, we can achieve outstanding results by doing something to raise disease awareness during mass vaccination, when almost all residents gather in a certain place, and school-based e-learning without face-to-face instruction due to the COVID-19 pandemic.
目的：我们在2021年8月至2022年6月期间前瞻性地开展了糸鱼川头痛认知宣传活动，进行了两项主要干预措施，并评估了其效果。 背景：头痛是一个常见的公共卫生问题，但通过提高对头痛的认识以及正确使用急性和预防性药物，可以减轻其负担。然而，关于提高公众头痛认知的研究报道较少。 方法：目标群体为15 - 64岁的普通公众。我们协同开展了两项主要干预措施，并辅以其他一些小的干预措施。干预1包括在新冠疫苗接种期间发放传单和一份关于头痛的纸质问卷，干预2包括通过学校进行按需电子学习和在线调查。在这些干预措施中，我们强调了《2021年头痛疾病临床实践指南》中描述的对普通公众而言重要的六个主题。收集了两项干预措施组在干预前后的每一项反馈。评估了活动前后对这六个主题的认知情况。 结果：我们从干预1中接种疫苗的6382人那里获得了4016份有效回复，从干预2中的594名学生和1983名家长那里获得了2577份有效回复；因此，糸鱼川市20458名劳动年龄总人口中的6593人（32.2%）参与了这些干预措施。在两项主要干预措施后，知晓这六个主题的个体百分比显著增加，从6.6%（39/594） - 40.0%（1606/4016）增至64.1%（381/594） - 92.6%（1836/1983）（所有p < 0.001）。 结论：我们通过两项主要干预措施开展了此次活动，提高了了解头痛知识的个体比例。这两种基于社区的干预方法能够有效提高头痛认知。此外，我们通过在几乎所有居民聚集在特定地点的大规模疫苗接种期间开展提高疾病认知的活动，以及在新冠疫情期间开展无需面对面教学的基于学校的电子学习，能够取得显著成效。
J Healthc Leadersh. 2023-11-1
Cephalalgia. 2017-10-10
Turk Psikiyatri Derg. 2021
Turk Psikiyatri Derg. 2021
Cochrane Database Syst Rev. 2018-5-8
J Headache Pain. 2025-7-15
Zotero 插件